LUPO, Antonio
 Distribuzione geografica
Continente #
EU - Europa 11.117
NA - Nord America 10.962
AS - Asia 6.967
SA - Sud America 1.117
AF - Africa 91
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 12
Totale 30.283
Nazione #
US - Stati Uniti d'America 10.824
RU - Federazione Russa 3.410
GB - Regno Unito 2.907
SG - Singapore 2.853
CN - Cina 2.422
BR - Brasile 924
SE - Svezia 923
DE - Germania 742
FR - Francia 725
IE - Irlanda 680
FI - Finlandia 654
IT - Italia 609
HK - Hong Kong 591
VN - Vietnam 439
UA - Ucraina 216
KR - Corea 187
AR - Argentina 82
IN - India 71
JP - Giappone 62
CA - Canada 59
ID - Indonesia 54
BE - Belgio 49
TR - Turchia 48
BD - Bangladesh 46
MX - Messico 40
AT - Austria 37
IQ - Iraq 33
ZA - Sudafrica 33
EC - Ecuador 31
PL - Polonia 29
ES - Italia 26
NL - Olanda 26
IL - Israele 23
CO - Colombia 21
MA - Marocco 17
UZ - Uzbekistan 17
AU - Australia 15
PY - Paraguay 15
VE - Venezuela 14
CL - Cile 13
EG - Egitto 13
AE - Emirati Arabi Uniti 12
EU - Europa 11
CZ - Repubblica Ceca 10
PK - Pakistan 10
AZ - Azerbaigian 9
LT - Lituania 9
RO - Romania 8
SA - Arabia Saudita 8
HR - Croazia 7
JM - Giamaica 7
NP - Nepal 7
TN - Tunisia 7
BH - Bahrain 6
BO - Bolivia 6
CH - Svizzera 6
GR - Grecia 6
IR - Iran 6
KE - Kenya 6
KG - Kirghizistan 6
TH - Thailandia 6
DO - Repubblica Dominicana 5
JO - Giordania 5
KZ - Kazakistan 5
PA - Panama 5
PE - Perù 5
PH - Filippine 5
PT - Portogallo 5
RS - Serbia 5
UY - Uruguay 5
DK - Danimarca 4
HN - Honduras 4
KH - Cambogia 4
LB - Libano 4
MY - Malesia 4
NI - Nicaragua 4
SV - El Salvador 4
TW - Taiwan 4
AL - Albania 3
BG - Bulgaria 3
BY - Bielorussia 3
HU - Ungheria 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
TT - Trinidad e Tobago 3
BB - Barbados 2
CG - Congo 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DZ - Algeria 2
EE - Estonia 2
GE - Georgia 2
KW - Kuwait 2
LU - Lussemburgo 2
LV - Lettonia 2
ME - Montenegro 2
NO - Norvegia 2
NZ - Nuova Zelanda 2
OM - Oman 2
PS - Palestinian Territory 2
Totale 30.261
Città #
Southend 2.455
Jacksonville 1.891
Chandler 1.442
Singapore 1.172
Moscow 1.023
Woodbridge 901
Dallas 774
Ann Arbor 714
Dublin 678
Ashburn 643
Hong Kong 589
Houston 542
Beijing 358
Wilmington 284
Lawrence 268
Princeton 268
Jinan 198
Nanjing 173
New York 172
Shenyang 166
Los Angeles 159
Buffalo 131
Helsinki 130
Verona 121
Boardman 118
Tianjin 112
Hebei 106
Dong Ket 101
Ho Chi Minh City 100
The Dalles 96
Sindelfingen 89
Columbus 83
São Paulo 82
Ningbo 66
Hanoi 65
Milan 65
Changsha 63
Haikou 63
Redondo Beach 61
Santa Clara 59
Tokyo 59
Zhengzhou 59
Nanchang 58
Council Bluffs 57
Guangzhou 56
Munich 55
Jiaxing 52
Brussels 49
Hangzhou 49
Lancaster 47
Seattle 47
Taizhou 44
Falls Church 41
Seoul 39
Taiyuan 38
Philadelphia 35
Jakarta 34
Norwalk 34
Lanzhou 33
San Francisco 33
Rio de Janeiro 32
Chicago 30
Turku 28
Nuremberg 27
Auburn Hills 26
London 26
Washington 26
Vienna 24
Kent 23
Warsaw 23
Rome 22
Brooklyn 21
Detroit 21
Redmond 21
Toronto 21
Fuzhou 20
Phoenix 20
Fairfield 19
Quito 19
Atlanta 18
Denver 18
Johannesburg 18
Redwood City 18
Venice 18
Belo Horizonte 17
Frankfurt am Main 17
Montreal 17
Falkenstein 15
Porto Alegre 15
Chennai 14
Düsseldorf 14
Haiphong 14
Bologna 13
Brasília 13
Dhaka 13
Campinas 12
Orem 12
Shanghai 12
Tashkent 12
Boston 11
Totale 18.260
Nome #
125I-iothalamate and creatinine clearances in patients with chronic renal diseases 253
DISREGOLAZIONE DELLA BIOSINTESI E DEL METABOLISMO DEI PROTEOGLICANI/GLICOSAMINOGLICANI NEI SOGGETTI UREMICI: UNO STUDIO DI GENOMICA FUNZIONALE 226
Low platelet glutathione peroxidase activity and serum selenium concentration in patients with chronic renal failure: relations to dialysis treatments, diet and cardiovascular complications 223
Eparanasi: un nuovo biomarker di fibrosi e un potenziale target farmacologico per ridurre la progressione del danno renale cronico 219
Adding access blood flow surveillance to clinical monitoring reduces thrombosis rates and costs, and improves fistula patency in the short term: a controlled cohort study. 188
Terapia della glomerulonefrite membrano proliferativa. 188
A napkin-associated outbreak of Burkholderia cenocepacia bacteraemia in haemodialysis patients. 182
A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy. 176
Endovascular versus Surgical Preemptive Repair of Forearm Arteriovenous Fistula Juxta-Anastomotic Stenosis: Analysis of Data Collected Prospectively from 1999 to 2004 176
A new mechanism of action of sulodexide in diabetic nephropathy: inhibits heparanase-1 and prevents FIG-2-induced renal epithelial-mesenchymal transition. 176
14-year experience with the double-cuff straight Tenckhoff catheter 175
A prospective, randomized trial of two antibiotic regimens in the treatment of peritonitis in CAPD patients: Teicoplanin plus tobramycin versus cephalothin plus tobramycin 175
A single dialysis session of hemodiafiltration with sorbent-regenerated endogenous ultrafiltrate reinfusion (HFR) removes hepcidin more efficiently than bicarbonate hemodialysis: a new approach to containing hepcidin burden in dialysis patients? 172
Cutaneous plasmacytoma in a hemodialysis patient. 171
IDENTIFICATION OF MOLECULAR BIOMARKERS FOR EARLY DIAGNOSIS OF DELAYED GRAFT FUNCTION IN RENAL TRANSPLANT RECIPIENTS 170
Long-Term (3 Years) Prognosis of Contrast-Induced Acute Kidney Injury After Coronary Angiography 169
A specific immune transcriptomic profile discriminates chronic kidney disease patients in predialysis from hemodialyzed patients. 167
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 166
Aspects of calcium metabolism in obstructive nephropathy: a metabolic and bone biopsy investigation 163
Alterations in renal tubular sodium and water transport in polycystic kidney disease 163
IDENTIFICAZIONE DI BIOMARCATORI MOLECOLARI PER LA DIAGNOSI PRECOCE DELLA FUNZIONALITÀ RITARDATA DELL'ORGANO TRAPIANTATO 161
Anaemia in diabetic renal failure: is there a role for early erythropoietin treatment in preventing cardiovascular mortality? 161
mTOR inhibitors and renal allograft: Yin and Yang. 160
In Vitro Identification of New Transcriptomic and miRNomic Profiles Associated with Pulmonary Fibrosis Induced by High Doses Everolimus: Looking for New Pathogenetic Markers and Therapeutic Targets. 158
Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. 157
Proteomic-based research strategy identified laminin subunit alpha 2 as a potential urinary-specific biomarker for the medullary sponge kidney disease. 156
The impact of pruritus on quality of life of patients undergoing dialysis: A single-center cohort study 156
Outcomes of the surgical revision of stenosed and thrombosed forearm arteriovenous fistulae for hemodialysis 155
An unusual association of contralateral congenital small kidney, reduced renal function and hyperparathyroidism in sponge kidney patients: on the track of the molecular basis. 154
NLRP3 Inflammasome Activation in Dialyzed Chronic Kidney Disease Patients. 153
Acute changes in renal function in IgA nephropathy 152
Downregulation of nuclear-encoded genes of oxidative metabolism in dialyzed chronic kidney disease patients. 152
Prevalence of CKD in northeastern Italy: results of the INCIPE study and comparison with NHANES. 150
Extra-renal adverse effects of mTOR inhibitors: know them to optimize their use in renal transplantation. 150
Everolimus-associated interstitial pneumonia in a renal transplant patient: a case report 149
Everolimus-induced epithelial to mesenchymal transition (EMT) in bronchial/pulmonary cells: when the dosage does matter in transplantation 149
Specific heparanase inhibition reverses glucose-induced mesothelial-to-mesenchymal transition. 148
Carbohydrate metabolism in patients with nephrotic syndrome and normal renal function 146
99mTc-Ca-gluconate renal scintigraphy in patients with chronic renal failure 146
La qualità della vita nell’anziano in dialisi [Quality of life of the elderly patient on dialysis]. 146
Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. 146
Monoclonal antibody therapy and renal transplantation: focus on adverse effects. 146
Bedside Screening for Fistula Stenosis Should Be Tailored to the Site of the Arteriovenous Anastomosis 145
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS 145
Epithelial to mesenchymal transition in the liver field: the double face of Everolimus in vitro. 143
Sirolimus and Everolimus Pathway: Reviewing Candidate Genes Influencing Their Intracellular Effects 143
Impact of maintenance immunosuppressive therapy on the fecal microbiome of renal transplant recipients: Comparison between an everolimus- and a standard tacrolimus-based regimen. 143
Unusual renal presentation of Fabry disease in a female patient. 142
The relationship between calcium kidney stones, arterial stiffness and bone density: unraveling the stone-bone-vessel liaison 142
How has peritoneal dialysis changed over the last 30 years: experience of the Verona dialysis center 142
3 years' experience in the prevention of recurrent calcic nephrolithiasis 141
Post-renal transplant pregnancy: a project to plan carefully 141
Metabolic Syndrome, Cardiovascular Disease, and Risk for Chronic Kidney Disease in an Italian Cohort: Analysis of the INCIPE Study. 140
Is it possible to use the identification of neutrophil gelatinase- associated lipocalin (NGAL) in the evaluation of bisphosphonates nephrotoxicity? [E' possibile utilizzare la determinazione della lipocalina associata alla gelatinasi dei neutrofili (NGAL) nella valutazione della nefrotossicità da bisfosfonati?] 140
Heparanase: A Potential New Factor Involved in the Renal Epithelial Mesenchymal Transition (EMT) Induced by Ischemia/Reperfusion (I/R) Injury. 140
ENDOTHELIAL PROGENITOR CELLS IN ACUTE RENAL INJURY 139
Familial clustering of medullary sponge kidney is autosomal dominant with reduced penetrance and variable expressivity. 139
A validated model of disease progression in IgA nephropathy. 137
Can blood flow surveillance and pre-emptive repair of subclinical stenosis prolong the useful life of arteriovenous fistulae? A randomized controlled study 137
Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents 137
Everolimus-induced epithelial to mesenchymal transition in immortalized human renal proximal tubular epithelial cells: key role of heparanase. 136
In search of an optimal bedside screening program for arteriovenous fistula stenosis 136
Proteomic Analysis of Urinary Microvesicles and Exosomes in Medullary Sponge Kidney Disease and Autosomal Dominant Polycystic Kidney Disease. 134
Altered thyroid in dialysed uremic patients 133
Red blood cells and platelet membrane fatty acids in non-dialyzed and dialyzed uremics 132
Effects of high doses of frusemide on plasma and muscle electrolytes in patients with chronic renal failure 132
High chronic nephropathy detection yield in CKD subjects identified by the combination of albuminuria and estimated GFR. 132
Sulodexide alone or in combination with low doses of everolimus inhibits the hypoxia-mediated epithelial to mesenchymal transition in human renal proximal tubular cells. 132
Renal lesions after unilateral ureterosigmoidostomy in the rabbit: preliminary results 131
Personalization of the Immunosuppressive Treatment in Renal Transplant Recipients: The Great Challenge in "Omics" Medicine. 131
Renal tubular defects in recurring bilateral nephrolithiasis 130
Cutaneous plasmacytoma in a hemodialysis patient. 130
GDNF gene Variants Associated with Medullary Sponge Kidney. Distinguish a Specific Clinical Phenotype. 130
Systemic and Nonrenal Adverse Effects Occurring in Renal Transplant Patients Treated with mTOR Inhibitors. 130
Red blood cell cation transports in uraemic anaemia: evidence for an increased K/Cl co-transport activity. Effects of dialysis and erythropoietin treatment. 129
Assessment of physical performance and body composition in male renal transplant patients 129
Practice patterns in the management of arteriovenous fistula stenosis: a northern Italian survey. 128
Genetic associations at 53 loci highlight cell types and biological pathways relevant for kidney function. 128
Rapporti tra adattamento, qualità di vita e supporto familiare, sociale nel paziente in trattamento dialitico. [Dialysis, adaptation, quality of life, and family support.] 127
Randall's plaque, calcium-sensing receptor, and idiopathic calcium nephrolithiasis 127
Pharmacogenetics: a promising tool to personalize immunosuppressive therapy in renal transplantation. 127
Antihypertensive, hemodynamic and endocrine effects of Captopril in arterial hypertension 126
Aspects of phosphate metabolism in kidney disease. The pre-eminence of extrarenal factors 126
Henoch-Schonlein purpura and Crohn's disease in a family. 126
Bone Disease in Medullary Sponge Kidney and Effect of Potassium Citrate Treatment. 126
Heparanase and syndecan-1 interplay orchestrates fibroblast growth factor-2-induced epithelial-mesenchymal transition in renal tubular cells. 126
Mitochondria: a new therapeutic target in chronic kidney disease. 126
Ten years experience of CAPD in diabetics: comparison of results with non-diabetics. Italian Cooperative Peritoneal Dialysis Study Group 125
Genome-wide association studies identify genetic loci associated with albuminuria in diabetes. 125
Transcriptomics: A Step behind the Comprehension of the Polygenic Influence on Oxidative Stress, Immune Deregulation, and Mitochondrial Dysfunction in Chronic Kidney Disease. 125
Safety and Efficacy of Citrate Anticoagulation for Continuous Renal Replacement Therapy for Acute Kidney Injury After Liver Transplantation: A Single-Center Experience. 125
mTOR Inhibition Role in Cellular Mechanisms 125
Basi scientifiche per la definizione di linee guida in ambito clinico per i tumori della prostata 124
Procalcitonin values after dialysis is closely related to type of dialysis membrane 124
Heparanase regulates the M1 polarization of renal macrophages and their crosstalk with renal epithelial tubular cells after ischemia/reperfusion injury 124
Heparanase is a key player in renal fibrosis by regulating TGF-β expression and activity. 123
New non-renal congenital disorders associated with medullary sponge kidney (MSK) support the pathogenic role of GDNF and point to the diagnosis of MSK in recurrent stone formers. 123
Dialysis-related transcriptomic profiling: The pivotal role of heparanase. 122
Mantenimento del trapianto renale: impatto clinico a lungo termine di tre diversi protocolli immunosoppressivi Risultati di un ampio studio multicentrico italiano 122
General practitioners' serum creatinine recording styles. 121
Totale 14.693
Categoria #
all - tutte 102.915
article - articoli 94.005
book - libri 0
conference - conferenze 4.137
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 4.773
Totale 205.830


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.582 0 0 0 0 318 298 34 194 165 17 323 233
2021/20221.677 96 363 18 178 64 52 39 113 88 50 150 466
2022/20234.371 328 426 471 662 419 1.100 53 267 444 23 121 57
2023/20241.717 99 176 163 198 235 231 27 117 16 76 261 118
2024/20254.810 312 351 174 825 225 160 194 269 729 290 375 906
2025/20267.251 1.060 696 913 2.121 2.461 0 0 0 0 0 0 0
Totale 30.558